Response to Comment on: Five-year visual field outcomes of the HORIZON trial.
Resource Type
Editorial & Opinion
Authors
Montesano G; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom; City University of London-Optometry and Visual Sciences, London, United Kingdom.; Ometto G; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom; City University of London-Optometry and Visual Sciences, London, United Kingdom.; Ahmed IIK; John Moran Eye Center, University of Utah, Salt Lake City, Utah, USA; Department of Ophthalmology, University of Toronto, Toronto, Canada.; Ramulu PY; Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.; Chang DF; Altos Eye Physicians, Los Altos, California, USA.; Crabb DP; City University of London-Optometry and Visual Sciences, London, United Kingdom.; Gazzard G; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom.
Source
Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE